✨ Education and Health Notices




NEW ZEALAND GAZETTE, No. 138

8 SEPTEMBER 2011

HON ANNE TOLLEY, Minister of Education.

Explanatory Note
This explanatory note is not part of the notice, but it is intended to indicate its general effect.

  • For the first elections for parent representatives and a staff representative, a returning officer will be appointed by the commissioner.

Private Schools Conditional Integration Act 1975

Supplementary Integration Agreement

Pursuant to section 10 of the Private Schools Conditional Integration Act 1975, notice is given that a supplementary integration agreement has been signed between the Minister of Education on behalf of Her Majesty The Queen, acting through the Group Manager, Education, Curriculum and Performance, Ministry of Education, pursuant to delegated authority, and the proprietor of the following school:

Richmond View School, Blenheim (421).

The said supplementary integration agreement was executed on 29 August 2011.

A copy of the supplementary integration agreement is available for inspection without charge by any member of the public via the following email address:

enquiries.nelson@minedu.govt.nz

Dated at Wellington this 29th day of August 2011.

JEREMY WOOD, Group Manager, Education, Curriculum and Performance.


Health

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Clindamycin ABM

  • Active Ingredient: Clindamycin hydrochloride 177.515mg equivalent to Clindamycin 150mg
  • Dosage Form: Capsule
  • New Zealand Sponsor: ABM Pharma Limited
  • Manufacturer: Chanelle Medical Limited, County Galway, Ireland

Product: Coumadin

  • Active Ingredient: Warfarin sodium 1mg
  • Dosage Form: Tablet
  • New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
  • Manufacturer: Aspen Pharma Pty Limited, Dandenong, Australia

Product: Coumadin

  • Active Ingredient: Warfarin sodium 2mg
  • Dosage Form: Tablet
  • New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
  • Manufacturer: Aspen Pharma Pty Limited, Dandenong, Australia

Product: Coumadin

  • Active Ingredient: Warfarin sodium 5mg
  • Dosage Form: Tablet
  • New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
  • Manufacturer: Aspen Pharma Pty Limited, Dandenong, Australia

Product: Nodia

  • Active Ingredient: Loperamide hydrochloride 2mg
  • Dosage Form: Tablet
  • New Zealand Sponsor: Multichem NZ Limited
  • Manufacturer: Cipla Limited, Maharashtra, India


Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2011, No 138





✨ LLM interpretation of page content

πŸŽ“ Supplementary Integration Agreement for Richmond View School

πŸŽ“ Education, Culture & Science
29 August 2011
Supplementary Integration Agreement, Richmond View School, Blenheim
  • HON ANNE TOLLEY, Minister of Education
  • JEREMY WOOD, Group Manager, Education, Curriculum and Performance

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
Medicines, Distribution, Clindamycin ABM, Coumadin, Nodia